Results for tag: "Anthrax Drug"

The Anthrax Drug market is a subset of the Infectious Diseases Drugs market, which focuses on the development and sale of drugs to treat and prevent anthrax. Anthrax is a serious bacterial infection caused by the bacterium Bacillus anthracis. It can be contracted through contact with infected animals or contaminated animal products, or through inhalation of the bacteria. Treatment of anthrax typically involves antibiotics, such as ciprofloxacin, doxycycline, and penicillin. Vaccines are also available to prevent anthrax infection. The Anthrax Drug market is highly competitive, with a number of companies offering products to treat and prevent anthrax. These include GlaxoSmithKline, Pfizer, Merck, and Sanofi. Other companies, such as Emergent BioSolutions, are also involved in the development of anthrax drugs. Show Less Read more